Gamma-tocotrienol, a radiation prophylaxis agent, induces high levels of granulocyte colony-stimulating factor

Shilpa Kulkarni, Lynnette H. Cary, Kristen Gambles, Martin Hauer-Jensen, K. Sree Kumar, Sanchita P. Ghosh

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

Gamma-tocotrienol (GT3), a promising radioprotectant, is shown to protect CD2F1 mice from radiation-induced neutropenia and thrombocytopenia when given 24 h prior to total-body irradiation. GT3 also is shown to increase white blood cells (WBC) and absolute neutrophil counts (ANC) transiently in peripheral blood. We hypothesized that increases in WBC and ANC may involve stimulation of hematopoiesis possibly by cytokines and growth factors. To evaluate the effects of GT3 on hematopoietic system, we measured various cytokines, chemokines and growth factors by cytokine array and Bio-Plex assays. Both showed strong induction of various cytokines and chemokines. GT3 treatment resulted in significant increases in G-CSF, IL-1α, IL-1β, IL-6, IL-12p70, IL-17, MIP-1α, and KC levels. G-CSF levels increased markedly within 12-24 h after administration (5441 pg/ml in GT3-treated groups compared to 17 pg/ml in vehicle control). Most of these cytokine levels were elevated in the presence or absence of radiation. Time-course analysis of G-CSF and IL-6 induction showed that both cytokines were induced transiently after GT3 administration, and returned to normal levels by 48 h post-administration. For G-CSF, the peak was observed between 12 and 24 h post-administration of GT3; however, the highest levels of IL-6 were obtained between 6 and 12 h. These results demonstrate that GT3 induced high levels of G-CSF and other inflammatory cytokines and chemokines within 24 h after administration. Survival studies reported showed that the most efficacious time for administering GT3 was 24 h prior to irradiation, possibly because it induced key hematopoietic cytokines in that time window. These results also suggest a possible role of GT3-induced G-CSF stimulation in protecting mice from radiation-induced neutropenia and thrombocytopenia.

Original languageEnglish (US)
Pages (from-to)495-503
Number of pages9
JournalInternational Immunopharmacology
Volume14
Issue number4
DOIs
StatePublished - Dec 2012
Externally publishedYes

Fingerprint

Granulocyte Colony-Stimulating Factor
Radiation
Cytokines
Chemokines
Interleukin-6
Neutropenia
Interleukin-1
Thrombocytopenia
Intercellular Signaling Peptides and Proteins
Neutrophils
Leukocytes
Hematopoietic System
Macrophage Colony-Stimulating Factor
Interleukin-17
plastochromanol 8
Whole-Body Irradiation
Hematopoiesis

Keywords

  • Cytokines
  • G-CSF
  • Gamma-tocotrienol
  • IL-6
  • KC
  • Radiation

ASJC Scopus subject areas

  • Immunology
  • Immunology and Allergy
  • Pharmacology

Cite this

Gamma-tocotrienol, a radiation prophylaxis agent, induces high levels of granulocyte colony-stimulating factor. / Kulkarni, Shilpa; Cary, Lynnette H.; Gambles, Kristen; Hauer-Jensen, Martin; Kumar, K. Sree; Ghosh, Sanchita P.

In: International Immunopharmacology, Vol. 14, No. 4, 12.2012, p. 495-503.

Research output: Contribution to journalArticle

Kulkarni, Shilpa ; Cary, Lynnette H. ; Gambles, Kristen ; Hauer-Jensen, Martin ; Kumar, K. Sree ; Ghosh, Sanchita P. / Gamma-tocotrienol, a radiation prophylaxis agent, induces high levels of granulocyte colony-stimulating factor. In: International Immunopharmacology. 2012 ; Vol. 14, No. 4. pp. 495-503.
@article{b41f0dac57b8477f9e081499949951ff,
title = "Gamma-tocotrienol, a radiation prophylaxis agent, induces high levels of granulocyte colony-stimulating factor",
abstract = "Gamma-tocotrienol (GT3), a promising radioprotectant, is shown to protect CD2F1 mice from radiation-induced neutropenia and thrombocytopenia when given 24 h prior to total-body irradiation. GT3 also is shown to increase white blood cells (WBC) and absolute neutrophil counts (ANC) transiently in peripheral blood. We hypothesized that increases in WBC and ANC may involve stimulation of hematopoiesis possibly by cytokines and growth factors. To evaluate the effects of GT3 on hematopoietic system, we measured various cytokines, chemokines and growth factors by cytokine array and Bio-Plex assays. Both showed strong induction of various cytokines and chemokines. GT3 treatment resulted in significant increases in G-CSF, IL-1α, IL-1β, IL-6, IL-12p70, IL-17, MIP-1α, and KC levels. G-CSF levels increased markedly within 12-24 h after administration (5441 pg/ml in GT3-treated groups compared to 17 pg/ml in vehicle control). Most of these cytokine levels were elevated in the presence or absence of radiation. Time-course analysis of G-CSF and IL-6 induction showed that both cytokines were induced transiently after GT3 administration, and returned to normal levels by 48 h post-administration. For G-CSF, the peak was observed between 12 and 24 h post-administration of GT3; however, the highest levels of IL-6 were obtained between 6 and 12 h. These results demonstrate that GT3 induced high levels of G-CSF and other inflammatory cytokines and chemokines within 24 h after administration. Survival studies reported showed that the most efficacious time for administering GT3 was 24 h prior to irradiation, possibly because it induced key hematopoietic cytokines in that time window. These results also suggest a possible role of GT3-induced G-CSF stimulation in protecting mice from radiation-induced neutropenia and thrombocytopenia.",
keywords = "Cytokines, G-CSF, Gamma-tocotrienol, IL-6, KC, Radiation",
author = "Shilpa Kulkarni and Cary, {Lynnette H.} and Kristen Gambles and Martin Hauer-Jensen and Kumar, {K. Sree} and Ghosh, {Sanchita P.}",
year = "2012",
month = "12",
doi = "10.1016/j.intimp.2012.09.001",
language = "English (US)",
volume = "14",
pages = "495--503",
journal = "International Immunopharmacology",
issn = "1567-5769",
publisher = "Elsevier",
number = "4",

}

TY - JOUR

T1 - Gamma-tocotrienol, a radiation prophylaxis agent, induces high levels of granulocyte colony-stimulating factor

AU - Kulkarni, Shilpa

AU - Cary, Lynnette H.

AU - Gambles, Kristen

AU - Hauer-Jensen, Martin

AU - Kumar, K. Sree

AU - Ghosh, Sanchita P.

PY - 2012/12

Y1 - 2012/12

N2 - Gamma-tocotrienol (GT3), a promising radioprotectant, is shown to protect CD2F1 mice from radiation-induced neutropenia and thrombocytopenia when given 24 h prior to total-body irradiation. GT3 also is shown to increase white blood cells (WBC) and absolute neutrophil counts (ANC) transiently in peripheral blood. We hypothesized that increases in WBC and ANC may involve stimulation of hematopoiesis possibly by cytokines and growth factors. To evaluate the effects of GT3 on hematopoietic system, we measured various cytokines, chemokines and growth factors by cytokine array and Bio-Plex assays. Both showed strong induction of various cytokines and chemokines. GT3 treatment resulted in significant increases in G-CSF, IL-1α, IL-1β, IL-6, IL-12p70, IL-17, MIP-1α, and KC levels. G-CSF levels increased markedly within 12-24 h after administration (5441 pg/ml in GT3-treated groups compared to 17 pg/ml in vehicle control). Most of these cytokine levels were elevated in the presence or absence of radiation. Time-course analysis of G-CSF and IL-6 induction showed that both cytokines were induced transiently after GT3 administration, and returned to normal levels by 48 h post-administration. For G-CSF, the peak was observed between 12 and 24 h post-administration of GT3; however, the highest levels of IL-6 were obtained between 6 and 12 h. These results demonstrate that GT3 induced high levels of G-CSF and other inflammatory cytokines and chemokines within 24 h after administration. Survival studies reported showed that the most efficacious time for administering GT3 was 24 h prior to irradiation, possibly because it induced key hematopoietic cytokines in that time window. These results also suggest a possible role of GT3-induced G-CSF stimulation in protecting mice from radiation-induced neutropenia and thrombocytopenia.

AB - Gamma-tocotrienol (GT3), a promising radioprotectant, is shown to protect CD2F1 mice from radiation-induced neutropenia and thrombocytopenia when given 24 h prior to total-body irradiation. GT3 also is shown to increase white blood cells (WBC) and absolute neutrophil counts (ANC) transiently in peripheral blood. We hypothesized that increases in WBC and ANC may involve stimulation of hematopoiesis possibly by cytokines and growth factors. To evaluate the effects of GT3 on hematopoietic system, we measured various cytokines, chemokines and growth factors by cytokine array and Bio-Plex assays. Both showed strong induction of various cytokines and chemokines. GT3 treatment resulted in significant increases in G-CSF, IL-1α, IL-1β, IL-6, IL-12p70, IL-17, MIP-1α, and KC levels. G-CSF levels increased markedly within 12-24 h after administration (5441 pg/ml in GT3-treated groups compared to 17 pg/ml in vehicle control). Most of these cytokine levels were elevated in the presence or absence of radiation. Time-course analysis of G-CSF and IL-6 induction showed that both cytokines were induced transiently after GT3 administration, and returned to normal levels by 48 h post-administration. For G-CSF, the peak was observed between 12 and 24 h post-administration of GT3; however, the highest levels of IL-6 were obtained between 6 and 12 h. These results demonstrate that GT3 induced high levels of G-CSF and other inflammatory cytokines and chemokines within 24 h after administration. Survival studies reported showed that the most efficacious time for administering GT3 was 24 h prior to irradiation, possibly because it induced key hematopoietic cytokines in that time window. These results also suggest a possible role of GT3-induced G-CSF stimulation in protecting mice from radiation-induced neutropenia and thrombocytopenia.

KW - Cytokines

KW - G-CSF

KW - Gamma-tocotrienol

KW - IL-6

KW - KC

KW - Radiation

UR - http://www.scopus.com/inward/record.url?scp=84867090918&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84867090918&partnerID=8YFLogxK

U2 - 10.1016/j.intimp.2012.09.001

DO - 10.1016/j.intimp.2012.09.001

M3 - Article

C2 - 23000517

AN - SCOPUS:84867090918

VL - 14

SP - 495

EP - 503

JO - International Immunopharmacology

JF - International Immunopharmacology

SN - 1567-5769

IS - 4

ER -